Depression and Anxiety in People with Epilepsy
Top Cited Papers
Open Access
- 1 January 2014
- journal article
- review article
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 10 (3), 175-188
- https://doi.org/10.3988/jcn.2014.10.3.175
Abstract
Many recent epidemiological studies have found the prevalence of depression and anxiety to be higher in people with epilepsy (PWE) than in people without epilepsy. Furthermore, people with depression or anxiety have been more likely to suffer from epilepsy than those without depression or anxiety. Almost one-third of PWE suffer from depression and anxiety, which is similar to the prevalence of drug-refractory epilepsy. Various brain areas, including the frontal, temporal, and limbic regions, are associated with the biological pathogenesis of depression in PWE. It has been suggested that structural abnormalities, monoamine pathways, cerebral glucose metabolism, the hypothalamic-pituitary-adrenal axis, and interleukin-1b are associated with the pathogenesis of depression in PWE. The amygdala and the hippocampus are important anatomical structures related to anxiety, and γ-aminobutyric acid and serotonin are associated with its pathogenesis. Depression and anxiety may lead to suicidal ideation or attempts and feelings of stigmatization. These experiences are also likely to increase the adverse effects associated with antiepileptic drugs and have been related to poor responses to pharmacological and surgical treatments. Ultimately, the quality of life is likely to be worse in PWE with depression and anxiety than in PWE without these disorders, which makes the early detection and appropriate management of depression and anxiety in PWE indispensable. Simple screening instruments may be helpful for in this regard, particularly in busy epilepsy clinics. Although both medical and psychobehavioral therapies may ameliorate these conditions, randomized controlled trials are needed to confirm that.Keywords
This publication has 136 references indexed in Scilit:
- Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessmentsEpilepsia, 2011
- Comorbidity between epilepsy and depression: Experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanismsEpilepsia, 2010
- Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsyNeurobiology of Disease, 2009
- Subjective perception of cognition is related to mood and not performanceEpilepsy & Behavior, 2009
- 5-HT1A Receptor Binding in Temporal Lobe Epilepsy Patients With and Without Major DepressionBiological Psychiatry, 2007
- Longitudinal associations between depressive and anxiety disorders: a comparison of two trait modelsPsychological Medicine, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of Internal Medicine, 2006
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Selecting an Antidepressant for Use in a Patient with EpilepsyDrug Safety, 1998
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983